Two Drugs, Distinct Profiles, One Goal: Individualised Treatment of MASH

Amedeo Lonardo, Ralf Weiskirchen
Current Pharmaceutical Analysis · Elsevier · 2026-11-01 · DOI: 10.1016/j.cpan.2026.11.002

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles